Take Your Trading To The Next Level. Get Started Here!
+1 (949) 514 8188
The company reiterated its full-year 2024 sales guidance of roughly $4 billion, which includes revenue from the expected launch of its RSV vaccine.
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
The company reiterated its full-year 2024 sales guidance of roughly $4 billion, which includes revenue from the expected launch of its RSV vaccine.
Archives
Categories
Archives
Recent Posts
Meta
Categories
Calender